Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it has delivered another strong revenue quarter. During Q2 of 2024, Melodiol generated unaudited revenue of$4.8m, a 9% increase on Q1 2024 ($4.4m). H2 2024 unaudited revenues now total $9.2m, a 31% increase on H1 2023…
(TheNewswire) Toronto, Ontario TheNewswire – July 2, 2024 Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB,…
North Arrow Minerals Inc. (TSXV: NAR) (‘ North Arrow’) is pleased to announce it has entered into an asset…
When asked about the most important drivers for silver right now, he pointed to the solar industry, noting that…
2024 has been a storybook year for gold. Gold prices saw significant gains through the first half of 2024…
(TheNewswire) Toronto, Ontario TheNewswire – July 2, 2024 Noble Mineral Exploration Inc. ( ‘Noble’ or the ‘Company’ ) (TSX-V:NOB,…
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas…
True North Copper Limited (ASX: TNC) (TNC or the Company) is pleased to announce mining operations at its Wallace…
Tryptamine Therapeutics Limited (‘Tryp’ or the ‘Company’) (ASX: TYP), a clinical-stage biotechnology company focused on the development of an…